About me
Mark Rutter is Vice President, Regulatory Affairs at Formation Bio, where he leads regulatory strategy across the development portfolio with a focus on innovative approaches to evidence generation. He brings extensive experience from leadership roles at Biogen, AbbVie, and Celgene, where he supported the advancement of therapies addressing significant unmet medical need. Mr. Rutter has led regulatory strategies incorporating novel endpoints and evidence frameworks, including accelerated approval pathways, and is recognized for his work at the intersection of regulatory science, policy, and innovation.
